Target intelligence / Profile preview

Lycii Radicis Cortex (Digupi) (LRC)

Target
LRC
Molecular classification
Other
01

Overview

Lycii Radicis Cortex, widely known by its Chinese name Digupi, is the dried root bark of Lycium chinense Miller or Lycium barbarum L., both of which belong to the Solanaceae family [1, 2, 7]. In traditional Chinese medicine (TCM), it is valued for its antipyretic, anti-inflammatory, and 'blood-cooling' properties, traditionally prescribed to treat 'bone-steaming' fever, chronic cough, and night sweats [1, 10, 16]. Modern pharmacological research indicates that Digupi possesses significant hypoglycemic, antioxidant, and hepatoprotective activities, making it a subject of interest for managing type 2 diabetes and hypertension [3, 22]. These effects are mediated by a diverse array of bioactive compounds, most notably kukoamines A and B, the coumarin scopoletin, and the steroid beta-sitosterol, which act on multiple cellular targets within the PI3K-Akt and cAMP-PKA signaling cascades [3, 8, 27]. Although frequently studied via network pharmacology to identify its multi-target mechanisms, Digupi is a complex botanical extract rather than a single molecular target or receptor [3, 14, 18].

Other names
DigupiCortex LyciiLycii CortexLycium root barkJigolpiGugo-pi
02

Mechanism of action

Exerts therapeutic effects through bioactive components like kukoamines, scopoletin, and beta-sitosterol which modulate intracellular signaling pathways such as cAMP-PKA, PI3K-Akt, and MAPK, while also inhibiting enzymes like cyclooxygenase-2 (COX-2), alpha-glucosidase, and dipeptidyl peptidase-4 (DPP-4) [3, 8, 27].

03

Biological functions

Signal transductionImmune responseMetabolic regulationCell deathOxidative stress response
04

Disease associations

Diabetes mellitusHypertensionInflammationNeurodegenerative diseaseCancerOther
05

Safety considerations

Potential for hypoglycemia when combined with anti-diabetic drugsPotential for hypotensive effectsPotential toxicity in cases of significant overdose
06

Biomarkers

Kukoamine AKukoamine BScopoletinBetaine

Beyond the preview

Go deeper on Lycii Radicis Cortex (Digupi) (LRC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lycii Radicis Cortex (Digupi) (LRC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call